Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin

J Pharmacol Sci. 2021 Dec;147(4):367-375. doi: 10.1016/j.jphs.2021.09.001. Epub 2021 Sep 11.

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder caused by CAG repeat expansion in the huntingtin (HTT) gene. Here, we examined the effects of antioxidants on 3-nitropropionic acid (3-NP; a mitochondrial complex II inhibitor)-induced mitochondrial dysfunction and cell death in STHdhQ111 striatal cells carrying homozygous mutant HTT with extended CAG repeats compared with those in STHdhQ7 striatal cells. 3-NP reduced cell viability and increased cell death both in STHdhQ111 and STHdhQ7, and the cytotoxicity was markedly attenuated by antioxidants (N-acetyl-l-cysteine and edaravone). Furthermore, 3-NP increased intracellular reactive oxygen species (ROS) production in both cell lines, and this increase was inhibited by antioxidants. Mitochondrial ROS was also increased by 3-NP in STHdhQ111 but not in STHdhQ7, and this increase was significantly inhibited by edaravone. Mitochondrial membrane potential (MMP) was lower in STHdhQ111 than that in STHdhQ7, and antioxidants prevented 3-NP-induced MMP decrease in STHdhQ111.3-NP enhanced oligomerization of dynamin-related protein 1 (Drp1), a protein that promotes mitochondrial fission in both cells, and both antioxidants prevented the increase in oligomerization. These results suggest that reduced mitochondrial complex II activity enhances cell death via intracellular ROS production and Drp1 oligomerization in striatal cells with mutant HTT and antioxidants may reduce striatal cell death.

Keywords: Dynamin-related protein 1; Mitochondrial complex II; Mutant huntingtin; Reactive oxygen species; Striatal neurons.

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Cell Death / drug effects*
  • Cell Death / genetics*
  • Edaravone / pharmacology
  • Electron Transport Complex II / antagonists & inhibitors
  • Electron Transport Complex II / metabolism*
  • Huntingtin Protein / genetics*
  • Huntington Disease / genetics*
  • Membrane Potential, Mitochondrial / drug effects
  • Mice, Transgenic
  • Mitochondria / drug effects*
  • Mitochondria / metabolism*
  • Mitochondrial Dynamics / drug effects
  • Mutation / genetics*
  • Nitro Compounds / adverse effects
  • Nitro Compounds / antagonists & inhibitors
  • Propionates / adverse effects
  • Propionates / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism*
  • Trinucleotide Repeat Expansion / genetics*

Substances

  • Antioxidants
  • Htt protein, mouse
  • Huntingtin Protein
  • Nitro Compounds
  • Propionates
  • Reactive Oxygen Species
  • Electron Transport Complex II
  • 3-nitropropionic acid
  • Edaravone